Verve Ventures

Verve Ventures is the leading European startup investment platform for qualified and institutional investors. Our fully digital platform enables private investors to build a diversified portfolio with investments starting at CHF/EUR 10'000. Since its launch in 2010, Verve Ventures has invested more than EUR 130 million in over 100 startups. Our community consists of 5’000 registered qualified private investors, family offices and pension funds. Several institutional investors such as a large Swiss pension fund and numerous corporates also rely on our expertise to invest in the most promising startups. Verve Ventures is backed by Switzerland's third-largest bank, Zürcher Kantonalbank. We have a dedicated investment team based in Zurich, Lausanne, Berlin, Paris and Cambridge, that screens thousands of startups each year and selects the top 1% after a rigorous due diligence process. We are reshaping the European venture capital landscape and granting investors superior access to this traditionally intransparent asset class. We source the best deals, structure rounds and enable our investors to participate in the most competitive startup deals.

Wassim Matar

Managing Partner

198 past transactions

ANYbotics

Series B in 2023
ANYbotics AG, founded in 2016 and based in Zurich, Switzerland, develops advanced four-legged robots designed for various industrial applications. These autonomous mobile robots are engineered to enhance safety and productivity by navigating complex environments and performing routine inspections. Equipped with a suite of advanced sensors including visual zoom cameras, lidar scanners, and thermal cameras, ANYbotics' robots can monitor assets, detect gas presence, and create 3D models. Their robust design allows for operation in challenging terrains, making them suitable for sectors such as power, chemicals, construction, mining, and oil and gas. By automating inspection tasks and providing real-time data, ANYbotics aims to improve operational efficiency and support critical functions such as search and rescue.

EcoRobotix

Series B in 2023
EcoRobotix Ltd is a Swiss company that develops, manufactures, and sells autonomous farming machines aimed at sustainable agriculture. Founded in 2011 and based in Yverdon-les-Bains, the company specializes in a solar-powered weeding robot designed for the ecological and economical management of row crops, meadows, and intercropping cultures. This innovative machine utilizes advanced vision systems, including cameras and GPS technology, to accurately navigate crop rows and identify weeds. By applying a micro dose of herbicide directly to the detected weeds, EcoRobotix significantly reduces chemical usage and minimizes environmental impact, while also lowering costs for farmers. The company's commitment to conserving soil and hydrological resources underscores its mission to provide precise and affordable robotic solutions that enhance food production.

MultiOmic Health

Seed Round in 2023
Operator of an artificial intelligence-driven drug discovery (AIDD) based precision medicine company intended to address metabolic syndrome-related diseases. The company's platform applies systems biology to discover therapeutics and diagnostics for treating metabolic syndrome patients, it combines integrated multi-omics analysis and computational systems biology modeling with targeted wet laboratory experiments to originate novel precision therapeutic concepts that commercialize via partnerships with established biopharma companies, enabling diagnostic companies to get access to new therapeutic and diagnostic research and development programs for subsequent co-developmentmore

Oper

Series A in 2022
Oper Credits is a technology company that specializes in providing software solutions to lenders for digitizing mortgage processes. Founded in 2018 and headquartered in Antwerp, Belgium, with an additional office in Zurich, Switzerland, Oper's platform streamlines various aspects of the mortgage journey, from loan requests to contract signing. It offers tools for customer verification, product advisory, collateral estimation, fraud detection, and scoring, allowing credit providers to launch digital mortgage products quickly and efficiently. By utilizing Oper's modular system, lenders can easily configure their processes and integrate Fintech technologies, enhancing their offerings and improving operational efficiency and conversion rates.

Nuclera

Series B in 2022
Nuclera is developing a bench-top gene and protein printer.

ORCA Computing

Series A in 2022
ORCA Computing Limited, founded in 2019 and based in Oxford, United Kingdom, specializes in the development of photonic quantum computers. The company is focused on creating a scalable and flexible quantum computing platform that utilizes quantum memories to enhance performance. By integrating proprietary memory technology with standard telecom components, ORCA Computing delivers a modular architecture that optimizes the storage, synchronization, and buffering of quantum operations. This innovative approach aims to unlock advanced applications across various industries, thereby accelerating innovation and transforming traditional computing methods.

Invasight

Seed Round in 2022
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. The company was founded in 2019 and is headquartered in Zurich, Switzerland.

Code Intelligence

Series A in 2022
Code Intelligence GmbH, founded in 2017 and based in Bonn, Germany, specializes in developing security software aimed at enhancing the reliability and security of software applications. The company offers modern security testing solutions utilizing coverage-based fuzzing techniques, which enable automated vulnerability detection and error checking with minimal expert intervention. Its products are designed for use by software developers, quality managers, and IT security firms, facilitating a continuous testing infrastructure that integrates the latest advancements in software testing technology. Code Intelligence serves prominent global clients, including Bosch, Deutsche Börse Group, and Deutsche Telekom, helping them ensure the security and robustness of their software systems.

Therapixel

Series B in 2022
Therapixel SA is a French company specializing in the development of artificial intelligence-based medical image analytics software aimed at enhancing surgical procedures. Founded in 2013 and headquartered in Valbonne, France, Therapixel offers a range of products designed to assist healthcare professionals, including Radvise, an automatic image reading solution; Fluid, a touchless navigation system for surgical environments; Anywhere, a post-processing workstation; and CD-Feed, a solution for importing outpatient imaging exams. The company's technology focuses on providing timely and relevant information to surgeons, ensuring they can access critical medical images before or during surgical operations. With additional locations in various countries, including Australia, China, and several nations across Europe and Latin America, Therapixel is committed to improving breast cancer detection and characterization through its innovative software solutions.

Therapixel

Series B in 2022
Therapixel SA is a French company specializing in the development of artificial intelligence-based medical image analytics software aimed at enhancing surgical procedures. Founded in 2013 and headquartered in Valbonne, France, Therapixel offers a range of products designed to assist healthcare professionals, including Radvise, an automatic image reading solution; Fluid, a touchless navigation system for surgical environments; Anywhere, a post-processing workstation; and CD-Feed, a solution for importing outpatient imaging exams. The company's technology focuses on providing timely and relevant information to surgeons, ensuring they can access critical medical images before or during surgical operations. With additional locations in various countries, including Australia, China, and several nations across Europe and Latin America, Therapixel is committed to improving breast cancer detection and characterization through its innovative software solutions.

Soter Analytics

Series A in 2022
Soter Analytics has developed the Soter Spine, a combination of wearable sensors and powerful analytics to predict and prevent musculoskeletal injuries in the workplace. Using machine learning and network effects from thousands of connected workers, the Soter Spine gets even smarter with time and will outperform current ergonomic standards. Soter will become the new standard in musculoskeletal injury prevention.

Minut

Series B in 2022
Minut is a technology company focused on smart home solutions, specializing in the development of a device called Point. Founded in 2014, with headquarters in Malmö, Sweden and operations in Shenzhen, China, Minut's product is designed to enhance home security by monitoring environmental factors such as noise, temperature, and motion without using cameras. The device employs infrared motion detection and microphones to identify unusual activities and send alerts to users' smartphones. This approach allows homeowners to maintain security and privacy while fostering good neighborly relations, particularly benefiting short-term rental hosts. Minut's technology represents a significant advancement in IoT and smart home management, providing users with peace of mind regarding their properties.

holo|one

Series A in 2022
holo | one is a Swiss IT start-up specializing in the development of augmented reality applications for companies. Their goal is to use our products and expertise to revolutionize industries and redefine work processes and processes.

Veesion

Series A in 2022
Veesion develops a gesture recognition technology in order to automatically detect shoplifting in the retail industry. Its deep learning algorithm analyses the content of security cameras and automatically detects gestures associated with shoplifting in real-time, as well as sends a video alert to a human operator who confirms the theft and takes action. The company was founded in 2018 and is based in Paris, France.

Oxford Medical Products

Venture Round in 2022
Oxford Medical Products is focused on developing an innovative gastro-retentive hydrogel technology aimed at addressing weight loss challenges. The company has created a self-expanding capsule that occupies space in the stomach, effectively reducing hunger and promoting significant weight loss. This technology is designed to expand rapidly upon ingestion, providing a lasting feeling of satiety. Over time, the capsule breaks down gradually and passes naturally through the digestive system. Comprising a team of scientists, medical professionals, and entrepreneurs, Oxford Medical Products is dedicated to providing a safe, effective, and affordable solution to one of the world's pressing health issues.

Zero Point Motion

Seed Round in 2022
Zero Point Motion creates inertial sensors that allow for precise positioning and navigation. They use cavity optomechanics in a hybrid micro-electro-mechanical system and photonic integrated circuit chip to provide an exceptionally low-noise readout of acceleration and rotation.

Memo Therapeutics

Series B in 2022
Memo Therapeutics AG, based in Basel, Switzerland, specializes in antibody discovery and immune repertoire analysis through its innovative MemoMAB platform. This technology enables the creation of a recombinant in vitro copy of an individual’s B cell and antibody repertoire, resulting in unique and extensive libraries that reflect a person's immune response. These libraries are anticipated to contain a significant number of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics employs its MemoMAB platform in proprietary antibody lead discovery programs and offers it for collaboration with other entities, enhancing the potential for novel therapeutic developments.

AlgoTrader

Series B in 2022
AlgoTrader AG specializes in developing algorithmic trading software tailored for quantitative hedge funds, enabling the automation of trading strategies across equity, foreign exchange, and derivatives markets. Founded in 2014 and headquartered in Zürich, Switzerland, AlgoTrader offers a comprehensive suite of tools that includes a user interface, reporting capabilities, automated cryptocurrency trading, order management, execution, and strategy development. The platform supports both traditional and crypto finance, allowing firms to conduct quantitative research, develop trading strategies, back-test them, and execute trades automatically. Recognized for being the first advanced software to facilitate automated trading of digital assets, AlgoTrader caters to a global client base from its offices in Zurich, New York, and Singapore.

Scrona

Series A in 2022
Scrona is all about simplifying micro- and nanotechnology, from the consumer- and industry-perspective. We offer solutions for convenient microscopic visualization and develop an ink-jet related printing technology that will revolutionize micro- and nanofabrication.

Nanoleq

Series A in 2021
Nanoleq AG is a Swiss technology startup founded in 2017 and based in Zurich. The company specializes in the development and manufacture of electric cables utilizing stretchable electronics and innovative conductive materials. Nanoleq's cables are designed to serve various sectors, including healthcare, robotics, aerospace, and electronics. These cables function both as shields and conductors, offering exceptional electrical properties, high mechanical flexibility, and extended durability. Through its cutting-edge approach, Nanoleq aims to revolutionize cable technology and address the evolving needs of diverse industries.

Hylomorph

Series B in 2021
Hylomorph AG is a MedTech company based in Zurich, Switzerland, focused on developing innovative solutions to address fibrotic encapsulation in implantable medical devices. Founded in 2014, the company specializes in a cellulose film designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of implant failure. This technology is particularly applicable in cardiac and plastic surgery, where it aids surgeons during the implantation of devices such as pacemakers and neurostimulators. Hylomorph combines advanced biotechnology and surface micro-engineering to enhance the interaction between biological tissues and medical implants, ultimately aiming to improve patient outcomes and the overall quality of healthcare.

Medimaps Group

Venture Round in 2021
Medimaps Group's mission is to design and provide medical tools to assist in the collection of quantitative information on bone microarchitecture for use in routine clinical practice. They enhance osteoporosis diagnosis by assessing the status of bone microarchitecture. They provide information to physicians to help them select the best treatment options for their patients and monitor treatment outcomes. They are working on future products to assess bone microarchitecture for application in the dental and orthopedic fields.

Kiutra

Venture Round in 2021
Kiutra GmbH, established in 2018 and based in Munich, Germany, specializes in manufacturing refrigeration solutions that utilize innovative magnetic cooling technology. This technology enables cryogen-free cooling services, achieving sub-kelvin temperatures essential for various applications, including basic research, material science, quantum technology, and advanced electronics. As a spin-off from the Technical University of Munich, kiutra benefits from a strong foundation in low-temperature physics and cryo-engineering, with a team that collectively possesses over 50 years of experience in the field. The company is currently supported by the "EXIST Transfer of Research" initiative, a program of the German Federal Ministry of Economic Affairs and Energy, aimed at fostering research-based startups. Kiutra's all-electrical cooling devices combine magnetic refrigeration and closed-cycle pre-cooling, making them accessible and efficient for research and industrial purposes that require cryogenic temperatures.

Comgy

Venture Round in 2021
Submetering

PathoQuest

Series B in 2021
PathoQuest SAS is a biotechnology company based in Paris, France, focused on advancing pathogen detection through a metagenomics approach. Founded in 2010 as a spin-off from Institut Pasteur, the company utilizes proprietary next-generation sequencing (NGS) technology to provide actionable reports for clinicians, biologists, and biopharmaceutical professionals. PathoQuest’s offerings include the iDTECTTM Dx Blood test for pathogen identification and a comprehensive database that enhances diagnostic accuracy. Additionally, the company provides Viral Safety testing services specifically designed for biopharmaceutical firms, which has quickly established a revenue stream from major industry players. The integration of advanced sample preparation and cloud-based bioinformatics enables improved detection capabilities across various biological samples, allowing healthcare professionals to address the limitations of traditional infectious agent detection methods.

Groover

Venture Round in 2021
Groover is an online platform designed to enhance music promotion and discovery for independent artists. Founded in 2018 and headquartered in Vauville, France, it allows musicians to submit their music to various media outlets, including blogs, radio stations, playlists, and record labels, using a virtual currency called Grooviz. The platform guarantees feedback from a community of music influencers, enabling artists to receive honest assessments of their work. By connecting musicians with key industry players, Groover facilitates the promotion of emerging talent and provides artists with opportunities for greater visibility in the competitive music landscape.

Aktiia

Series A in 2021
Aktiia SA, founded in 2018 and based in Neuchâtel, Switzerland, specializes in the development and manufacture of a blood pressure monitoring device. The company's flagship product is a smart bracelet equipped with optical sensors that continuously tracks users' systolic and diastolic blood pressure throughout the day and night. This data is accessible via an intuitive mobile app, allowing users to monitor their health conveniently. The bracelet's measurements are supported by clinically validated software algorithms, ensuring accuracy and reliability. The Aktiia platform also enables users to log their readings for personal use or share them with healthcare professionals. Through its innovative approach, Aktiia aims to empower individuals to better understand and manage their blood pressure, addressing a critical health concern effectively.

Seervision

Funding Round in 2021
Seervision AG is a Swiss company established in 2016, specializing in software development for camera automation aimed at improving storytelling and production efficiency. Based in Zurich, Seervision integrates advanced technologies such as machine learning and computer vision to assist broadcasters and production companies in automating camera movements and framing. The company’s innovative solutions leverage video analysis algorithms and motion control technology to facilitate fully automated productions, enabling features like autonomous camera tracking, facial recognition, and scene understanding. This technology allows cameramen to maintain optimal framing of subjects without manual intervention, enhancing the overall quality of hybrid meetings and productions.

Scewo

Series A in 2021
Scewo AG is a medical technology company based in Winterthur, Switzerland, specializing in the design and manufacture of innovative electric wheelchairs for individuals with disabilities. Founded in 2017, Scewo focuses on developing advanced mobility solutions, including a unique stair-climbing wheelchair that enhances accessibility for users. The company's commitment to improving the quality of life for disabled individuals drives its efforts in creating functional and adaptive mobility devices.

Locatee

Funding Round in 2021
Locatee AG is a Zurich-based company that specializes in workplace analytics, providing solutions aimed at optimizing office space utilization. Founded in 2014, Locatee offers an analytics platform that measures office occupancy without the need for hardware. By leveraging data from various sources and employing unique patent-pending technology, Locatee transforms complex information into clear insights. This enables corporate leaders to make informed decisions regarding their real estate, identify optimization opportunities, and enhance the overall workplace experience. The platform is designed to cater to the evolving challenges of modern corporate real estate, allowing organizations to achieve significant savings and improve the effectiveness of their office spaces.

EstateGuru

Series A in 2021
EstateGuru operates an online marketplace that specializes in short- and mid-term property loans across Continental Europe. The platform connects investors with businesses in need of asset-backed financing, thereby facilitating access to short-term property loans. By offering mortgage-backed loans, EstateGuru provides investors an opportunity to diversify their portfolios with real estate-related assets. The company also manages funds and payouts, ensuring a streamlined investment experience for both borrowers and lenders. Through its services, EstateGuru addresses the financing needs of businesses while offering secured investment options to its users.

Fractory

Series A in 2021
Fractory Ltd is a Manchester-based company that specializes in an online platform for sheet metal fabrication. Founded in 2019, it enables users to upload CAD files and efficiently matches orders with partner service providers based on availability, location, and capabilities. The platform offers a variety of services, including laser cutting, plasma cutting, tube laser cutting, oxy cutting, waterjet cutting, metal bending, and surface treatment. Fractory serves as a manufacturing marketplace that allows companies to discover, compare, and fulfill production orders of any batch size. Its automated quoting system provides quick pricing, eliminating the need for extensive communication, thus optimizing the use of specialized machinery and accelerating return on investment for users.

Sleepiz

Series A in 2021
Sleepiz AG is a Zurich-based startup focused on developing innovative solutions for sleep disorder screening and chronic disease management. Founded in 2018, Sleepiz manufactures a non-contact sleep monitoring device that can be placed on a bedside table. This device utilizes advanced wireless millimeter wave technology, sensor fusion, and artificial intelligence to accurately track vital parameters such as breathing, heart rate, and body movements. By enabling real-time assessment of sleep patterns and long-term monitoring, Sleepiz aims to facilitate timely interventions and enhance treatment outcomes for patients. The company's mission is to support the medical community in transitioning healthcare into home environments, allowing for more accessible and patient-centric care.

Humanoo

Series B in 2021
Humanoo is a digital health platform focused on enhancing employee health and productivity. It offers personalized health coaching and tailored daily exercises designed to improve overall wellbeing. By promoting health and wellness, Humanoo aims to reduce the frequency of annual doctor visits and foster greater happiness in both professional and personal life. The platform incorporates gamification features and health promotion programs, making it easier for employees to engage in their health journeys and ultimately boost their performance at work.

Otoqi

Series A in 2021
Developer of an automotive management platform designed to address the entire lifecycle of a vehicle. The company's platform brings instant ordering, visibility, and real-time control while buying a new or used car, streamlines operations by transferring vehicles quickly between sites, agencies, and partners and offers vehicle testing and after-sales services, enabling customers to have access to a full range of services to meet their needs.

byrd

Series B in 2021
byrd technologies GmbH is a third-party logistics and fulfillment company based in Vienna, Austria, founded in 2016. The company specializes in digital fulfillment services tailored for e-commerce businesses, offering solutions such as warehousing, pick and pack, shipping, quality control, and batch fulfillment. By operating an extensive fulfillment network, byrd connects online merchants with an international warehouse system, enabling retailers to provide advanced shipping options without the need to establish their own logistics infrastructure. The platform integrates seamlessly with popular e-commerce systems like Shopify and collaborates with logistics partners across multiple countries. In addition to its core markets in Germany and Austria, byrd has expanded its operations to include fulfillment locations in the UK and plans to launch new sites in the Netherlands and France. With the capacity to ship 10,000 orders daily from over ten warehouses, the company manages a storage space exceeding 500,000 square meters while also offering services like shipment tracking and product return management.

Threatray

Seed Round in 2021
Threatray produces code-based threat intelligence by making massive malware repositories and feeds searchable and correlatable. Their code-based threat intelligence and advanced analytics tools enable enterprise security and incident response teams to develop a deep understanding of cyber-attacks and to quickly and effectively detect, investigate, and disrupt attacks.

EcoRobotix

Venture Round in 2021
EcoRobotix Ltd is a Swiss company that develops, manufactures, and sells autonomous farming machines aimed at sustainable agriculture. Founded in 2011 and based in Yverdon-les-Bains, the company specializes in a solar-powered weeding robot designed for the ecological and economical management of row crops, meadows, and intercropping cultures. This innovative machine utilizes advanced vision systems, including cameras and GPS technology, to accurately navigate crop rows and identify weeds. By applying a micro dose of herbicide directly to the detected weeds, EcoRobotix significantly reduces chemical usage and minimizes environmental impact, while also lowering costs for farmers. The company's commitment to conserving soil and hydrological resources underscores its mission to provide precise and affordable robotic solutions that enhance food production.

Stake

Seed Round in 2021
Stake is a digital platform that facilitates real estate investment, allowing individuals to invest in income-generating rental properties quickly and easily. The platform aims to modernize real estate investment by making it accessible to a broader audience. Stake achieves this by breaking down properties into smaller, investable shares, thereby enabling users to purchase stakes in residential properties. This approach not only democratizes real estate investment but also enhances transparency and profitability for investors. Through its innovative model, Stake provides a streamlined way for individuals to engage in the real estate market without the complexities traditionally associated with property investment.

Sympatient

Seed Round in 2021
Sympatient GmbH is a digital therapeutics company based in Hamburg, Germany, specializing in virtual reality-based psychotherapy for anxiety disorders. Founded in 2017, the company develops medical applications aimed at improving mental health through innovative technology. Its flagship products, Otemi and Invirto, provide users with tasks, exercises, and therapeutic information to help manage anxiety and stress. Otemi focuses on reducing personal stress levels, while Invirto offers strategies for independent treatment of anxiety disorders at home. Sympatient's solutions integrate app-based cognitive behavioral therapy (CBT) with mobile virtual reality, allowing patients to learn about their conditions and engage in exposure therapy. The company's offerings are supported by licensed therapists and are reimbursed by major health insurance providers in Germany, making effective anxiety therapy accessible from home.

FineHeart

Series B in 2021
The company intends to use the funds to finance the development of its first product.France-based medical device company focused on innovative technologies in the cardiovascular space

EarlySight

Seed Round in 2021
EarlySight SA is a Swiss company, established in 2016 and based in Lausanne, that focuses on developing innovative medical devices for the early detection and treatment of eye diseases. The company has created an advanced eye fundus camera that enhances retinal imaging through precise illumination and real-time correction of ocular aberrations. This device utilizes cellular-level imaging technology to identify subtle structural changes in the retina, allowing for effective monitoring of treatment outcomes in a quick and non-invasive manner. By facilitating the visualization of cell morphology within the retina, EarlySight aims to improve the capabilities of eye specialists in diagnosing and managing ocular conditions.

Qnami

Series A in 2021
Qnami AG manufactures non-invasive sensors. Its products include ProteusQ, non-invasive magnetic imaging microscope; and Quantum Diamond, which includes Quantilevers MX, diamond probes containing a single NV for high resolution magnetic imaging, and NV diamond membranes, ready-to-use diamond with NV centers. Its applications are multiferroic antiferromagnet, antiferromagnetic ram, microwave imaging, magnetic nanomemories, and superconductivity. Qnami AG was founded in 2017 and is based in Basel, Switzerland.

MedTrace

Series B in 2021
MedTrace Pharma A/S is a medical device company based in Kongens Lyngby, Denmark, with additional offices in Boston, Massachusetts, and Uppsala, Sweden. Founded in 2015, the company specializes in the development of innovative solutions for positron emission tomography (PET) imaging. Its flagship product, the MT-100, is an automated system designed for on-site production and infusion of the tracer 15O-water, which enhances the sensitivity of PET scans and improves patient throughput. MedTrace also offers aQuant, an analytical platform that interprets the PET scan results, enabling physicians to obtain accurate blood flow measurements in various clinical applications, including heart studies and tumor vascularization. The integration of these technologies aims to revolutionize PET diagnostic imaging by providing safer and more efficient tools for healthcare professionals.

Qnami

Series A in 2021
Qnami AG manufactures non-invasive sensors. Its products include ProteusQ, non-invasive magnetic imaging microscope; and Quantum Diamond, which includes Quantilevers MX, diamond probes containing a single NV for high resolution magnetic imaging, and NV diamond membranes, ready-to-use diamond with NV centers. Its applications are multiferroic antiferromagnet, antiferromagnetic ram, microwave imaging, magnetic nanomemories, and superconductivity. Qnami AG was founded in 2017 and is based in Basel, Switzerland.

rready

Seed Round in 2021
Rready is an innovation management platform that empowers employees to harness their ambition and creativity, fostering a culture of intrapreneurship within organizations. By providing strategic and hands-on support, the platform facilitates cultural transformation and generates tangible business impacts while enhancing employer branding. Rready's approach combines gamification and scalable online components with offline activities, making the process of employee-driven innovation engaging and educational. This model encourages clients to implement and expand their innovative initiatives, allowing employees to take ownership of their ideas and contribute to the organization's growth. Through its solutions, Rready aims to create lasting cultural change and drive significant business outcomes.

rready

Seed Round in 2021
Rready is an innovation management platform that empowers employees to harness their ambition and creativity, fostering a culture of intrapreneurship within organizations. By providing strategic and hands-on support, the platform facilitates cultural transformation and generates tangible business impacts while enhancing employer branding. Rready's approach combines gamification and scalable online components with offline activities, making the process of employee-driven innovation engaging and educational. This model encourages clients to implement and expand their innovative initiatives, allowing employees to take ownership of their ideas and contribute to the organization's growth. Through its solutions, Rready aims to create lasting cultural change and drive significant business outcomes.

Onward

Convertible Note in 2021
Onward is a company focused on developing mobile applications and online platforms that assist users in modifying compulsive behaviors related to technology and financial management. It combines data science and artificial intelligence to create personalized programs aimed at addressing issues such as excessive screen time, social media use, gambling, and spending habits. The company also offers financial wellness solutions, including direct savings plans and emergency lending options to help individuals build financial security. Established in 2015 and based in Los Angeles, California, Onward's mission centers around restoring a balance between technology and life by providing accessible and non-judgmental resources for behavior change. Through collaboration with clinical advisors from UCLA, Onward seeks to utilize advanced behavioral science to reach a broad audience globally.

3YOURMIND

Series A in 2021
3YOURMIND GmbH, founded in 2013 and headquartered in Berlin, Germany, with additional offices in San Francisco and Wroclaw, develops an innovative software platform for industrial 3D printing. The company provides enterprise software that automates additive manufacturing processes, streamlining workflows for various industries. Its product suite encompasses tools for managing the entire additive manufacturing supply chain, from analyzing historical data to optimizing order management and production scheduling. By standardizing workflows and automating associated business processes, 3YOURMIND enables data-driven decision-making and supports agile manufacturing practices. Their solutions, including Agile PLM and Agile ERP, enhance product innovation and order tracking, while Agile MES improves transparency and information flow on the production floor. The company has successfully partnered with notable clients such as GKN, DB Schenker, and EOS, offering expert guidance throughout the additive manufacturing workflow, from concept to execution.

Oper

Convertible Note in 2021
Oper Credits is a technology company that specializes in providing software solutions to lenders for digitizing mortgage processes. Founded in 2018 and headquartered in Antwerp, Belgium, with an additional office in Zurich, Switzerland, Oper's platform streamlines various aspects of the mortgage journey, from loan requests to contract signing. It offers tools for customer verification, product advisory, collateral estimation, fraud detection, and scoring, allowing credit providers to launch digital mortgage products quickly and efficiently. By utilizing Oper's modular system, lenders can easily configure their processes and integrate Fintech technologies, enhancing their offerings and improving operational efficiency and conversion rates.

Kooky

Seed Round in 2021
- What is kooky? kooky is a digital cup smart system and offers you the possibility to dispose your reusable cup on your way in an easy and sustainable way through kooky boxes. - How does kooky work? You order your drink as usual and get it in a kooky cup. You simply pay for the drink plus 1 CHF deposit. When you return the cup in a kooky drop off box, you will immediately get your 1 CHF deposit credited in the wallet of your app. - What do I have to do when I got the cup with the drink? Simply scan the QR code of the cup with the kooky app (registration required), and the cup will be paired to your app account. - Where can I return the cup? In all the kooky boxes around town and in all the venues of the kooky network. You can find both in the app. - How do I get my credit? In order to withdraw the credit in your app wallet, you need to enter your bank details in the app. Then you submit a payout request of the desired amount. Kooky only takes a 10% fee as cost of service, you will receive a receipt for each withdrawal. - What does kooky do with the cups? Our employees empty the kooky boxes and bring the cups to our rinsing logistics. There, they are cleaned according to hygiene regulations and standards, picked, packed and distributed to our partners again. - Are e-vehicles used for logistics? Yes, the logistics for collecting and distributing the cups takes place exclusively with electric vehicles.

Waffle Labs

Seed Round in 2021
Waffle Labs, Inc. is a technology company based in New York that specializes in developing financial services software to assist customers in managing their investments. Founded in 2018 by Michael Li, Quentin Coolen, and Sam Barnsley, the company aims to reinvent insurance and enhance value for consumers. Through its innovative approach, Waffle Labs seeks to provide solutions that improve the financial management experience for its users.

Artifakt

Series A in 2021
Artifakt SAS, founded in 2017 and based in Paris, France, specializes in developing cloud platforms for the deployment and management of web projects. The company offers a range of solutions including Magento, an open-source ecommerce platform; Akeneo, a product information management tool; WordPress, a widely used software for creating websites and blogs; and Symfony, a framework for building web applications and services. Artifakt aims to streamline the process of cloud deployment, enabling digital teams to manage their web projects autonomously and efficiently, allowing developers to focus on creating innovative solutions.

Cognism

Series C in 2021
Cognism is a sales-acceleration solution that offers businesses an efficient way to prospect through its software as a service (SaaS) model. The company leverages a unique data asset and compliance engine to enrich customer relationship management (CRM) records and streamline the sales funnel. By utilizing patented artificial intelligence technology, Cognism generates and cleans prospect data at scale, providing B2B sales teams with real-time insights into company, people, and event data. This enables sales organizations to identify opportunities, recognize customer trends, and ultimately drive new revenue. Cognism's platform integrates seamlessly with major CRM and email service systems, facilitating effective database management and delivering high-quality, real-time B2B data to clients. Founded in 2015 and headquartered in London, Cognism also has offices in the USA, Macedonia, Croatia, and Singapore.

Frontastic

Venture Round in 2021
Frontastic GmbH, founded in 2017 and based in Münster, Germany, specializes in providing a frontend as a service platform tailored for e-commerce. The company offers cloud-based software solutions that facilitate the integration of e-commerce systems with its platform, allowing users to create reusable web components and build customized sites. Frontastic's approach is centered on a "mobile first" philosophy, enabling online retailers, brands, marketplaces, and startups to enhance the digital customer experience with minimal IT effort. The platform serves as a comprehensive solution, providing tools for developers, online editors, and end customers, and has quickly gained recognition as a leading front-end solution in the API economy.

RAW Labs

Seed Round in 2021
RAW Labs SA is a company based in Lausanne, Switzerland, established in 2015, that specializes in data management solutions for organizations facing the challenges of Big Data. The company offers innovative tools that allow users to build and deploy data-driven applications without the need for traditional data lakes or warehouses. Its flagship products include NoDB, which manages diverse and dispersed data in real time, and RQL (Raw Query Language), a query engine designed to expose raw and operational data efficiently. RAW Labs SA caters to data engineers, data scientists, and data analysts by providing a comprehensive platform for data exploration, analysis, and mining, which integrates seamlessly with existing environments. This enables organizations to directly query data across various formats and storage systems, streamlining their operations and reducing costs associated with data management.

Oper

Seed Round in 2021
Oper Credits is a technology company that specializes in providing software solutions to lenders for digitizing mortgage processes. Founded in 2018 and headquartered in Antwerp, Belgium, with an additional office in Zurich, Switzerland, Oper's platform streamlines various aspects of the mortgage journey, from loan requests to contract signing. It offers tools for customer verification, product advisory, collateral estimation, fraud detection, and scoring, allowing credit providers to launch digital mortgage products quickly and efficiently. By utilizing Oper's modular system, lenders can easily configure their processes and integrate Fintech technologies, enhancing their offerings and improving operational efficiency and conversion rates.

Threatray

Seed Round in 2021
Threatray produces code-based threat intelligence by making massive malware repositories and feeds searchable and correlatable. Their code-based threat intelligence and advanced analytics tools enable enterprise security and incident response teams to develop a deep understanding of cyber-attacks and to quickly and effectively detect, investigate, and disrupt attacks.

NetGuardians

Series D in 2020
NetGuardians SA is a software company based in Yverdon-les-Bains, Switzerland, specializing in mitigation and risk assurance solutions for the banking and financial services sectors. Founded in 2007, the company utilizes big data, user behavior analysis, and transaction analytics to help financial institutions combat various types of fraud, including mobile banking and identity theft. Its key products include FraudGuardian, which addresses specific fraud challenges with predefined controls for continuous auditing, and RiskGuardian, a compliance automation tool that offers templates for regulations, automated controls, and reporting capabilities. Serving CIOs, CISOs, internal auditors, and compliance professionals across Europe, the Middle East, Asia, and Africa, NetGuardians provides its solutions through resellers, ensuring adaptability for various fields of activity. The company also maintains offices in Nairobi, Warsaw, and Singapore.

RAW Labs

Series A in 2020
RAW Labs SA is a company based in Lausanne, Switzerland, established in 2015, that specializes in data management solutions for organizations facing the challenges of Big Data. The company offers innovative tools that allow users to build and deploy data-driven applications without the need for traditional data lakes or warehouses. Its flagship products include NoDB, which manages diverse and dispersed data in real time, and RQL (Raw Query Language), a query engine designed to expose raw and operational data efficiently. RAW Labs SA caters to data engineers, data scientists, and data analysts by providing a comprehensive platform for data exploration, analysis, and mining, which integrates seamlessly with existing environments. This enables organizations to directly query data across various formats and storage systems, streamlining their operations and reducing costs associated with data management.

EcoRobotix

Series C in 2020
EcoRobotix Ltd is a Swiss company that develops, manufactures, and sells autonomous farming machines aimed at sustainable agriculture. Founded in 2011 and based in Yverdon-les-Bains, the company specializes in a solar-powered weeding robot designed for the ecological and economical management of row crops, meadows, and intercropping cultures. This innovative machine utilizes advanced vision systems, including cameras and GPS technology, to accurately navigate crop rows and identify weeds. By applying a micro dose of herbicide directly to the detected weeds, EcoRobotix significantly reduces chemical usage and minimizes environmental impact, while also lowering costs for farmers. The company's commitment to conserving soil and hydrological resources underscores its mission to provide precise and affordable robotic solutions that enhance food production.

Comphya

Funding Round in 2020
Comphya Sàrl is a Swiss company founded in 2017, specializing in the design and development of active implantable medical devices aimed at restoring erectile function in patients who do not respond to oral medications. Its flagship product, CaverSTIM, utilizes neuromodulation to facilitate natural penile erections. The device comprises an implantable pulse generator, a multi-electrode array, and external controllers that allow for self-controlled stimulation via a wireless remote. Comphya's innovation provides a safe and effective alternative for a significant portion of the male population suffering from erectile dysfunction, ultimately enhancing their quality of life.

Perfood

Series A in 2020
Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digital therapeutics. A digital solution that is just as effective as a drug. But without side effects.

GUURU

Series A in 2020
GUURU is a cloud-based platform that connects users with experts across various fields to facilitate consultancy services. Founded in 2015 and based in Zurich, Switzerland, the company provides an intermediary platform where individuals can post questions and receive real-time answers through a one-on-one live chat feature. This service allows brands to leverage knowledgeable customers, referred to as brand ambassadors, to enhance customer interaction and support. By combining artificial intelligence with human expertise, GUURU enables efficient resolution of customer queries, thus expediting decision-making processes for potential buyers. The platform also supports seamless communication among students, allowing them to collaborate on assignments and share resources anonymously.

Verity

Convertible Note in 2020
Verity Studios AG, founded in 2014 and based in Zurich, Switzerland, develops and supplies advanced indoor drone systems tailored for the live entertainment industry. The company specializes in creating interactive and autonomous flying machines, including synthetic swarms and stage flyers. Verity Studios offers end-to-end drone show production services for a variety of events, theatrical productions, and entertainment shows. Its innovative technology has been showcased at prominent events, such as the TED 2016 conference, the Broadway show PARAMOUR by Cirque du Soleil, Metallica’s arena tour, and New York Knicks pre-game shows at Madison Square Garden. Through the integration of technological innovation and artistic design, Verity Studios is redefining the possibilities of drone performances in live settings.

CREAL

Series A in 2020
CREAL3D SA, founded in 2017 and based in Ecublens, Switzerland, specializes in developing advanced light field technology for virtual reality and mixed reality headsets. This innovative technology enhances immersion by projecting images with genuine optical depth, addressing common issues such as eye strain, nausea, and discomfort associated with existing headsets. Additionally, CREAL's near-eye light-field display is designed to be compact and easy to manufacture, positioning the company as a key player in improving user experience in immersive technologies.

Memo Therapeutics

Series B in 2020
Memo Therapeutics AG, based in Basel, Switzerland, specializes in antibody discovery and immune repertoire analysis through its innovative MemoMAB platform. This technology enables the creation of a recombinant in vitro copy of an individual’s B cell and antibody repertoire, resulting in unique and extensive libraries that reflect a person's immune response. These libraries are anticipated to contain a significant number of relevant and rare antibodies, opening new avenues for immune repertoire analysis and antibody discovery. Memo Therapeutics employs its MemoMAB platform in proprietary antibody lead discovery programs and offers it for collaboration with other entities, enhancing the potential for novel therapeutic developments.

Scailyte

Seed Round in 2020
Scailyte AG is a Swiss company specializing in artificial intelligence-based software solutions for biomedical research and precision diagnostics. Founded in 2017 and located in Sursee, Scailyte has developed a data-driven biomarker discovery platform that focuses on the analysis of single-cell data. This platform enables the identification of a new class of biomarkers based on the molecular profiles of disease-associated cells, providing a novel approach to biomarker discovery that is closely aligned with disease biology. By enhancing the analysis of complex single-cell data, Scailyte's solutions aim to improve the efficiency and effectiveness of pharmaceutical discovery and patient stratification, ultimately reducing data analysis time and costs while delivering valuable insights for healthcare providers.

Insolight

Series A in 2020
Insolight is an energy company that develops and manufactures solar panels. Insolight has developed solar modules with record efficiency 29 percent to reduce residential solar electricity costs below 0.1 $/kWh. Its innovative optical technology combines high efficiency with the ease of mounting of a standard flat panel. Insolight has successfully passed third-party validation at Fraunhofer ISE (36% efficiency on Lab prototype) and at the UPM in Madrid (29% on pre-industrial module). Its business model is to develop the IP, control wholesale distribution and outsource manufacturing. The company was founded in 2015.

ARTIRIA Medical

Series A in 2020
Artiria Medical SA develops micro-actuated device to treat vascular diseases. Its products bring micromotion deep in the brain arteries, enabling a navigation and stroke treatment. It empowers catheters and guidewires. Artiria Medical SA was incorporated in 2019 and is based in Lausanne, Switzerland.

Metaco

Series A in 2020
Metaco SA, founded in 2014 and based in Lausanne, Switzerland, specializes in cryptocurrency wallet management and custody solutions for banks and financial institutions. The company offers SILO, a secure cryptocurrency storage platform that enables institutions to manage transactions and store digital assets safely. With a focus on integrating advanced blockchain technologies into existing financial systems, Metaco has established itself as a leader in providing high-grade cryptographic solutions. Its expertise has attracted a diverse range of clients, including national banks, enabling them to capitalize on the growing importance of digital assets while ensuring robust security and compliance.

Metaco

Series A in 2020
Metaco SA, founded in 2014 and based in Lausanne, Switzerland, specializes in cryptocurrency wallet management and custody solutions for banks and financial institutions. The company offers SILO, a secure cryptocurrency storage platform that enables institutions to manage transactions and store digital assets safely. With a focus on integrating advanced blockchain technologies into existing financial systems, Metaco has established itself as a leader in providing high-grade cryptographic solutions. Its expertise has attracted a diverse range of clients, including national banks, enabling them to capitalize on the growing importance of digital assets while ensuring robust security and compliance.

Beekeeper

Series B in 2020
Beekeeper AG is a developer of a mobile-first communication platform designed for non-desk employees, facilitating real-time communication and productivity among frontline and mobile workforces. Founded in 2012 and headquartered in Zurich, Switzerland, with additional operations in Kraków, Berlin, and Oakland, Beekeeper serves various industries including hospitality, retail, logistics, transportation, food, manufacturing, NGOs, and event management. The platform offers tools such as messaging, content management, employee surveys, and engagement analytics, enabling managers to streamline workflows and enhance team productivity. By integrating operational systems into a central hub, Beekeeper allows users to communicate, share files, and assign tasks efficiently across different shifts and locations, thereby improving employee engagement and reducing turnover.

Pregnolia

Series A in 2020
Pregnolia AG is a Swiss company specializing in the development of diagnostic devices aimed at predicting the risk of premature birth during pregnancy consultations. Founded in 2015 and based in Zurich, the company has created a medical probe that measures the stiffness of the uterine cervix, which is a critical factor in assessing cervical status and mitigating the risk of premature delivery. This technology enables gynecologists to make informed decisions regarding birth management, ultimately improving neonatal health outcomes. Pregnolia's mission is to ensure that every woman can experience a healthy and informed pregnancy, as they work towards completing clinical trials and navigating regulatory processes to bring their product to market. The company focuses on addressing both health and economic challenges associated with preterm birth, aiming to enhance the care provided by doctors and midwives globally.

Code Intelligence

Series A in 2020
Code Intelligence GmbH, founded in 2017 and based in Bonn, Germany, specializes in developing security software aimed at enhancing the reliability and security of software applications. The company offers modern security testing solutions utilizing coverage-based fuzzing techniques, which enable automated vulnerability detection and error checking with minimal expert intervention. Its products are designed for use by software developers, quality managers, and IT security firms, facilitating a continuous testing infrastructure that integrates the latest advancements in software testing technology. Code Intelligence serves prominent global clients, including Bosch, Deutsche Börse Group, and Deutsche Telekom, helping them ensure the security and robustness of their software systems.

Mobbot

Seed Round in 2020
Mobbot SA, founded in 2018 and headquartered in Fribourg, Switzerland, specializes in 3D concrete printing technology tailored for the construction industry. The company offers a digital fabrication system that allows construction firms to produce custom-made concrete products efficiently. By integrating passive reinforcement and utilizing standard concrete from ready-mix plants, Mobbot's technology significantly reduces production and installation costs. This innovative approach enables clients to expedite their projects, compressing what would typically be a three-day job site workload into just one hour, thereby enhancing productivity in infrastructure development.

Sherpany

Series B in 2020
Sherpany is a leading provider of digital boardroom solutions, catering to some of Europe's largest companies. The company specializes in developing enterprise-grade meeting management software that streamlines executive and board meetings. Its SaaS-based platform enhances board collaboration and facilitates effective meeting management, allowing organizations to focus on critical decision-making. By improving the efficiency and productivity of formal meetings, Sherpany helps companies transform these gatherings into valuable opportunities for strategic development.

Sympatient

Seed Round in 2020
Sympatient GmbH is a digital therapeutics company based in Hamburg, Germany, specializing in virtual reality-based psychotherapy for anxiety disorders. Founded in 2017, the company develops medical applications aimed at improving mental health through innovative technology. Its flagship products, Otemi and Invirto, provide users with tasks, exercises, and therapeutic information to help manage anxiety and stress. Otemi focuses on reducing personal stress levels, while Invirto offers strategies for independent treatment of anxiety disorders at home. Sympatient's solutions integrate app-based cognitive behavioral therapy (CBT) with mobile virtual reality, allowing patients to learn about their conditions and engage in exposure therapy. The company's offerings are supported by licensed therapists and are reimbursed by major health insurance providers in Germany, making effective anxiety therapy accessible from home.

Neo Medical

Series A in 2020
Neo Medical SA is a medical technology company based in Villette, Switzerland, with additional offices in Germany, France, and the United States. Founded in 2013, the company specializes in developing, manufacturing, and commercializing non-constraint thoraco-lumbar spinal fusion systems for spinal surgery. Its flagship product, the Neo Pedicle Screw System, offers a range of functionalities such as reduction, compression, distraction, and screw augmentation, addressing various pathologies including degenerative conditions, tumors, and trauma. Neo Medical aims to enhance the efficiency of healthcare delivery by providing versatile and high-quality surgical solutions, thereby contributing to the ongoing pursuit of healthcare cost optimization.

Bring!

Series B in 2020
Bring! Labs AG, founded in 2015 and based in Zürich, Switzerland, develops a comprehensive application that streamlines the grocery shopping experience for users on various platforms, including iPhone, Android, Web, Alexa, and Google Assistant. The Bring! app allows users to create, manage, and share grocery lists, making it easier to plan meals and collaborate with family or housemates. It offers integrated features such as recipes, online shopping options, local offers, and loyalty card management, catering to the needs of both online and offline shoppers. With a focus on saving time and money, Bring! enhances the shopping process while also providing innovative marketing opportunities for advertisers. The company has expanded its operations to include an office in Mannheim, Germany, and employs around 20 people.

Andjaro

Series B in 2020
Andjaro is a software platform designed to enhance workforce management in medium and large organizations, particularly those with operations across multiple locations. The platform facilitates the mapping, reallocation, and load balancing of internal staff, enabling companies to utilize available and willing employees from different sites instead of relying on costly temporary or fixed-term contract workers. This approach not only reduces expenses significantly, with clients reportedly saving over €15 million, but also allows employees to gain experience in various parts of the organization through temporary relocations. By providing comprehensive visibility into available resources, Andjaro helps managers address staffing gaps, absences, or overstaffing efficiently, fostering a more interconnected and satisfied workforce. The platform has successfully facilitated over 120,000 staff movements to date.

Alaya

Seed Round in 2020
The platform empowers companies to build a purpose-driven culture and engage employees to make an impact, one act at a time. We enable experiences that bring out the human side of work, so that companies and their employees can do good and measure their actions every day. By volunteering, giving, or taking simple actions such as biking to work, saving energy, or committing to a healthier lifestyle, your employees are able to participate in your organisation’s efforts to activate your purpose.

AVAtronics

Seed Round in 2020
AVAtronics SA is a company based in Lausanne, Switzerland, founded in 2016, that specializes in developing advanced noise-canceling technology for a variety of electronic devices such as headphones, earbuds, hearing aids, and speakerphones. The company has created an Active Noise Cancellation (ANC) solution characterized by low power consumption and wide-band capabilities, allowing it to effectively eliminate unwanted noises while maintaining high-quality audio for music and speech.

Aktiia

Seed Round in 2020
Aktiia SA, founded in 2018 and based in Neuchâtel, Switzerland, specializes in the development and manufacture of a blood pressure monitoring device. The company's flagship product is a smart bracelet equipped with optical sensors that continuously tracks users' systolic and diastolic blood pressure throughout the day and night. This data is accessible via an intuitive mobile app, allowing users to monitor their health conveniently. The bracelet's measurements are supported by clinically validated software algorithms, ensuring accuracy and reliability. The Aktiia platform also enables users to log their readings for personal use or share them with healthcare professionals. Through its innovative approach, Aktiia aims to empower individuals to better understand and manage their blood pressure, addressing a critical health concern effectively.

Archilyse

Series A in 2020
Archilyse AG, founded in 2017 and headquartered in Zurich, Switzerland, specializes in software for numeric architectural analysis tailored to the real estate sector. The company offers a Software-as-a-Service solution that simplifies the analysis and evaluation of architectural quality through an application programming interface. By converting 2D floor plans and building images into 3D models, Archilyse enables users to conduct various simulations, such as view, geometrical, connectivity, and physical analyses. These simulations provide valuable insights presented in heatmaps or key figure tables, facilitating informed decision-making for portfolio managers, real estate developers, and valuers. Archilyse aims to enhance the real estate lifecycle by leveraging digitization, addressing the information imbalance in the industry, and maximizing benefits for all stakeholders involved.

Scipio Bioscience

Series A in 2020
Scipio Bioscience is a biotechnology company based in Paris, France, founded in 2017. The company specializes in manufacturing benchtop kits that serve as a sample preparation solution for single-cell studies. These kits are designed for use in sequencing applications within both clinical and basic research, focusing particularly on transcriptomics. By enabling single-cell barcoding in a test tube format, Scipio Bioscience's products facilitate advanced research in single-cell analysis, supporting laboratories in their scientific endeavors.

OncoDNA

Series B in 2020
OncoDNA SA is a Belgium-based company specializing in precision medicine for cancer treatment and genetic diseases. Founded in 2012, it leverages over 60 years of expertise in medical diagnostics, particularly in DNA sequencing and oncology analyses. The company offers a range of solutions, including OncoDEEP, a comprehensive theranostics tool for solid tumors that integrates DNA, RNA, and protein analysis to assist oncologists in making informed treatment decisions. Additionally, OncoDEEP&TRACE allows for the profiling of both solid and liquid biopsies, while OncoTRACE provides a personalized, non-invasive blood test for monitoring tumor progression and treatment efficacy. OncoSHARE facilitates collaboration among patients, oncologists, and the oncology community by streamlining sample management and data sharing. OncoDNA distributes its products both locally in Belgium and globally, supporting clinical guidance and research in oncology and genetic disorders.

9T Labs

Seed Round in 2020
9T Labs brings together advanced software, additive manufacturing and industry-standard materials to deliver digital composite production solution. With proprietary 9T Labs Additive Fusion Technology (AFT) technology , manufacturers can create lighter structural parts with true 3d fibre orientation and mass-produce carbon composite at lower cost. Intuitive design software for optimal fiber placement and automated production equipment allows companies to increase competitiveness throughout their whole value chain.

Biograil

Seed Round in 2020
Biograil, established in 2019 and led by CEO Karsten Lindhardt, specializes in developing a medical device that aims to enhance drug delivery systems. The device, produced through injection molding, is designed to fit within a standard-sized capsule and delivers active substances directly into the gastrointestinal wall. By utilizing the body's natural peristaltic forces, Biograil's technology eliminates the need for mechanical moving parts, allowing for a more efficient and pain-free administration of biologics. This innovative approach addresses the common challenges associated with traditional injection systems, offering a promising alternative for patients requiring medication.

AlgoTrader

Series A in 2020
AlgoTrader AG specializes in developing algorithmic trading software tailored for quantitative hedge funds, enabling the automation of trading strategies across equity, foreign exchange, and derivatives markets. Founded in 2014 and headquartered in Zürich, Switzerland, AlgoTrader offers a comprehensive suite of tools that includes a user interface, reporting capabilities, automated cryptocurrency trading, order management, execution, and strategy development. The platform supports both traditional and crypto finance, allowing firms to conduct quantitative research, develop trading strategies, back-test them, and execute trades automatically. Recognized for being the first advanced software to facilitate automated trading of digital assets, AlgoTrader caters to a global client base from its offices in Zurich, New York, and Singapore.

CREAL

Series A in 2020
CREAL3D SA, founded in 2017 and based in Ecublens, Switzerland, specializes in developing advanced light field technology for virtual reality and mixed reality headsets. This innovative technology enhances immersion by projecting images with genuine optical depth, addressing common issues such as eye strain, nausea, and discomfort associated with existing headsets. Additionally, CREAL's near-eye light-field display is designed to be compact and easy to manufacture, positioning the company as a key player in improving user experience in immersive technologies.

Nagi Bioscience

Seed Round in 2019
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes Caenorhabditis elegans, a type of microscopic worm, for the assessment of substances in pharmaceutical, chemical, and cosmetic industries. This technology, known as "Organism-on-Chip," integrates in vivo testing with a fully automated in vitro platform for handling, culturing, and analyzing these organisms. Nagi Bioscience's solutions facilitate toxicity testing, drug discovery, and anthelmintic testing, allowing clients to gain insights into the complete biological responses that can only be observed at the organism level. This approach aims to transform traditional methods of evaluating the toxic or beneficial effects of various substances.

Qnami

Seed Round in 2019
Qnami AG manufactures non-invasive sensors. Its products include ProteusQ, non-invasive magnetic imaging microscope; and Quantum Diamond, which includes Quantilevers MX, diamond probes containing a single NV for high resolution magnetic imaging, and NV diamond membranes, ready-to-use diamond with NV centers. Its applications are multiferroic antiferromagnet, antiferromagnetic ram, microwave imaging, magnetic nanomemories, and superconductivity. Qnami AG was founded in 2017 and is based in Basel, Switzerland.

Picstars

Venture Round in 2019
Picstars AG is a Swiss company founded in 2014, specializing in an online platform that connects brands with influencers, particularly in the sports and lifestyle sectors. The platform facilitates the identification of suitable brand ambassadors who utilize their social media channels to execute marketing campaigns, including photo, video, and hashtag promotions. Through its user-friendly interface, Picstars allows companies to create and manage advertising campaigns while providing tools for performance tracking and success measurement. This technology-driven marketplace aims to streamline the sponsorship process, enhancing the connection between brands and influencers to effectively meet marketing objectives. Based in Zürich, Picstars has gained recognition as one of the leading tech startups in Switzerland.

Avrios

Series B in 2019
Avrios International AG, founded in 2015 and based in Zürich, Switzerland, specializes in developing software for fleet and mobility management. The company offers a comprehensive Fleet Management Platform that enables organizations to efficiently manage employee transportation and fleet data. By integrating various data sources, Avrios automates processes and provides real-time insights, allowing users to optimize their fleet operations. The software collects relevant information in a centralized database and performs necessary calculations, facilitating informed decision-making and improved efficiency in fleet management.

Yonder

Seed Round in 2019
Yonder AG, founded in 2015 and based in Zurich, Switzerland, specializes in developing a documentation-as-a-service (DaaS) solution. The company offers Yonder Mind, an application software that enhances information management by allowing organizations to create, maintain, and deliver relevant information effectively. Yonder's platform is designed to provide a user-friendly experience, presenting the right information at the right time based on user profiles and context, thereby improving end-user satisfaction. Additionally, Yonder AG offers services for document content creation and conversion, facilitating shorter documents and manageable revisions to help users find and utilize relevant information more efficiently.

Versantis

Series B in 2019
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, it originated as a spin-off from ETH Zurich. The company's lead candidate, VS-01, is in preclinical development and aims to address acute liver disease while supporting multiple failing organs, targeting three rare indications and having received Orphan Drug Designation for acute liver failure. Versantis also has products in its pipeline, including VS-02 and VS-03, which are designed to treat chronic liver diseases and drug intoxications, respectively. These treatments aim to meet significant unmet medical needs and have the potential to enhance patient outcomes across various medical fields.

Beekeeper

Series B in 2019
Beekeeper AG is a developer of a mobile-first communication platform designed for non-desk employees, facilitating real-time communication and productivity among frontline and mobile workforces. Founded in 2012 and headquartered in Zurich, Switzerland, with additional operations in Kraków, Berlin, and Oakland, Beekeeper serves various industries including hospitality, retail, logistics, transportation, food, manufacturing, NGOs, and event management. The platform offers tools such as messaging, content management, employee surveys, and engagement analytics, enabling managers to streamline workflows and enhance team productivity. By integrating operational systems into a central hub, Beekeeper allows users to communicate, share files, and assign tasks efficiently across different shifts and locations, thereby improving employee engagement and reducing turnover.

Haelixa

Seed Round in 2019
Haelixa LLC specializes in DNA-based tracing and tagging technology aimed at enhancing supply chain transparency and integrity. Founded in 2012 and headquartered in Zürich, Switzerland, the company offers a range of solutions including water and oil tracers that help in monitoring and characterizing oil and geothermal reservoirs, as well as groundwater tracing. Haelixa's technology supports product identification, which aids in preventing counterfeiting and addressing other irregularities in the supply chain. The company provides customized solutions tailored to specific applications, enabling clients to authenticate products across various sectors, including textiles, precious metals, and raw materials, thereby safeguarding brand integrity and ensuring consumer trust.

PathoQuest

Series A in 2019
PathoQuest SAS is a biotechnology company based in Paris, France, focused on advancing pathogen detection through a metagenomics approach. Founded in 2010 as a spin-off from Institut Pasteur, the company utilizes proprietary next-generation sequencing (NGS) technology to provide actionable reports for clinicians, biologists, and biopharmaceutical professionals. PathoQuest’s offerings include the iDTECTTM Dx Blood test for pathogen identification and a comprehensive database that enhances diagnostic accuracy. Additionally, the company provides Viral Safety testing services specifically designed for biopharmaceutical firms, which has quickly established a revenue stream from major industry players. The integration of advanced sample preparation and cloud-based bioinformatics enables improved detection capabilities across various biological samples, allowing healthcare professionals to address the limitations of traditional infectious agent detection methods.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.